| Literature DB >> 35456559 |
Elizaveta S Permyakova1,2, Anton S Konopatsky1, Konstantin I Ershov2, Ksenia I Bakhareva2, Natalya A Sitnikova2, Dmitry V Shtansky1, Anastasiya O Solovieva2, Anton M Manakhov2.
Abstract
This study focused on the synthesis and characterization of pure curdlan-chitosan foams (CUR/CS), as well as foams containing Ag nanoparticles (CUR/CS/Ag), and their effect on the skin repair of diabetic mice (II type). The layer of antibacterial superabsorbent foam provides good oxygenation, prevents bacterial infection, and absorbs exudate, forming a soft gel (moist environment). These foams were prepared from a mixture of hydrolyzed curdlan and chitosan by lyophilization. To enhance the antibacterial properties, an AgNO3 solution was added to the curdlan/chitosan mixture during the polymerization and was then reduced by UV irradiation. The membranes were further investigated for their structure and composition using optical microscopy, scanning electron microscopy, energy-dispersive spectroscopy, FT-IR spectroscopy, and XPS analysis and modeling. In vivo tests demonstrated that CUR/CS/Ag significantly boosted the regeneration process compared with pure CUR/CS and the untreated control.Entities:
Keywords: XPS modelling; chitosan; curdlan; diabetic wound regeneration; silver nanoparticles; superabsorbent dressings
Year: 2022 PMID: 35456559 PMCID: PMC9032745 DOI: 10.3390/pharmaceutics14040724
Source DB: PubMed Journal: Pharmaceutics ISSN: 1999-4923 Impact factor: 6.525
Figure 1Schematic of curdlan/chitosan and curdlan/chitosan/Ag foam synthesis.
Figure 2Schematics of the possible chemical interactions between curdlan and chitosan.
Figure 3Optical and SEM images of CUR/CS and CUR/CS/Ag samples.
Atomic percentage (%) from energy dispersive X-ray (E.D.X.) element mapping.
| Samples | Atomic Percentage (%) | ||||
|---|---|---|---|---|---|
| C | O | N | Ag | Pt | |
| CUR/CS | 53.0 | 41.0 | 5.8 | - | 0.2 |
| CUR/CS-Ag | 52.6 | 40.2 | 6.6 | 0.4 | 0.2 |
Atomic percentages (%) obtained from the XPS surface analyses.
| Atomic Percentage (%) | Samples | |||
|---|---|---|---|---|
| CS | CUR | CUR/CS | CUR/CS/Ag | |
| C | 68.6 | 62.8 | 60.6 | 63.7 |
| O | 22.6 | 37.2 | 31.2 | 32.1 |
| N | 8.8 | 0.0 | 8.2 | 3.8 |
| Ag | 0.0 | 0.0 | 0.0 | 0.4 |
Figure 4XPS C1s curve fitting of CS (a), CUR (b), and CS-CUR-Ag (c).
Figure 5XPS O1s curve fitting of CS (a), CUR (b), and CS-CUR-Ag (c) samples.
Figure 6XPS curve fitting of N1s signal of CS (a) and CS-CUR-Ag (b) samples, and Ag 3D spectrum of CS-CUR-Ag (c).
Figure 7FTIR spectra of curdlan-chitosan (a), and CUR/CS and CUR/CS/Ag (b) biomaterials.
Figure 8PBS absorption capacity of the CUR/CS and CUR/CS/Ag biomaterials.
Figure 9The representative photographs showing the healing dynamic of full-thickness skin with (right wound) or without (left wound) treatment with curdlan/chitosan and curdlan/chitosan/Ag foams, for each of the groups of animals, n = 3. The ovals show the foams of the treated wounds. Wounds were covered with biomaterials for 10 days, after which healing occurred without the influence of biomaterials.
Figure 10The influence of membranes (red—CUR/CS; black—CUR/CS/Ag; blue—untreated control) on the dynamics of the wound defect closure. The graph shows the dynamics of the closure of a full-thickness skin defect in mice with genetically determined type 2 diabetes mellitus. Each animal (n = 3 in each group in total) received a control wound (without therapy) and an experimental wound (treatment with test materials). The percentage of closure was calculated based on the initial size of the wounds in order to assess the actual dynamics of healing. The graph shows the increase in the sparing of the control wounds for all observation times, as well as wounds with CUR/CS therapy on day 10 (removal of the dressing).
Figure 11Histology analysis of a full-thickness cutaneous defect after treatment with membranes. Yellow squares enclose the edge of the wound. Red arrows indicate infiltrating inflammatory cells (polymorphonuclear lymphocytes; number of animals in each group of dressings, n = 3).
Recent studies of the developed dressings for wound healing.
| № | Dressings | Size of Wound | Observations In Vivo | Animal | Reference |
|---|---|---|---|---|---|
| 1 | Structure: nanofibers had a diameter between 200 to 300 nm, size of NPs 50–100 nm | Wound: 1.5 cm × 1.5 cm | The wound closure rate of the negative control group was 18.46%, 59.89%, 62.42%, and 88.07%, and the wound closure rate of the positive control group was 25.33%, 72.85%, 95.32%, and 97.90% for 3, 7, 11, and 15 days, respectively | Rat | [ |
| 2 | Structure: film and gel functionalized by NPs (11.5–18.71 nm) | Burn rea: 1400 ± 50 mm2 | On day 21, the wound area treated with BC-ZnO NPs-BDP films was reduced by 34.3%, while when treated with ZnO NPs-BDP oleogel, a large decrease of up to 40.6% was observed. In the untreated control, the closure rate was just 19.2% | Rat | [ |
| 3 | Structure: electrospun fibers (648.1 ± 72.2 nm) with NPs | 12 mm square skin wounds | 80% contraction in wound area vs. 62% in the untreated control on 8 days | Diabetic mice | [ |
| 4 | Structure: hydrogel with NPs (size 99.1 ± 2.3 nm) | 20 mm square skin wounds | A 47.7 ± 1.8% contraction in the wound area was recorded with the AgNPs impregnated chitosan-PEG hydrogel group, compared to 12.6 ± 1.3% in the negative control | Diabetic | [ |
| 5 | Standard of care dressings impregnated with copper oxide microparticles (COD) | 9.26 ± 6.9 cm2 (range of 1.35–23.6 cm2) | Following 1 month of copper improved treatment, there was a clear reduction in the mean wound area (53.2%; | Clinic diabetic foot ucler | [ |
| 6 | Structure: hydrogel | 8-mm diameter round-shaped wound | On day 10, wound closure was 80% for hydrogel with thrombomodulin vs. the 40% untreated control | Mice | [ |
| 7 | Structure: electrospun fibers (90–120 nm) | 10-mm diameter round-shaped wound | On day 9, the wound contraction rate for the PVA/EPP1 group reached nearly 72% vs. 54% for the control group | Diabetic | [ |
| 8 | Structure: electrospun fibers (110 ± 74 nm) | 1 cm × 1 cm | βG-nanofibers 95% healing vs. 40% healing of control in 24 days | Diabetic mice | [ |
| 9 | Structure: hydrogel Composition: chitosan, heparin and poly (γ-glutamic acid) and loaded with superoxide dismutase | 10-mm diameter round-shaped wound | After 21 days, closure rate is 92.0% ± 3.7% compared with the control group (85.4% ± 2.4%) | Diabetic mice | [ |
| 10 | Structure: hydrogel Composition: glycol chitosan, loaded by growth factors (VEGF and PDGF-BB) | 5-mm diameter round-shaped wound | On day 3, hydrogel dressing demonstrated 60% closure rate vs. less than 5% for the Duoderm dressing | Diabetic mice | [ |